CG Oncology Inc.
CGON | NASDAQ
$78.25
+$3.63 (+4.86%)
At close: Sep 21, 2026, 4:00 PM ET
$78.23
-$0.02 (-0.03%)
Pre-market:
Sep 22, 2026, 6:00 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.23M | 5.07M | 4.04M | 2.17M | 551K | 662K | 1.14M | 684K | 650K | 539K | 204K | 203K | 194K | 194K | n/a |
Cost of Revenue | 11.38M | 38.78M | 63.29M | 87.18M | 105.22M | 92.36M | 64.9M | 38.1M | 30.21M | 11.75M | 19.59M | 19.59M | 7.85M | 7.85M | 4K |
Gross Profit | -5.15M | -33.71M | -59.25M | -85M | -104.67M | -91.7M | -63.76M | -37.42M | -29.56M | -11.21M | -19.38M | -19.38M | -7.66M | -7.65M | -4K |
Operating Income | -252.62M | -214.96M | -190.77M | -180.12M | -157.29M | -134.4M | -114.67M | -95.55M | -81.3M | -67.77M | -55.02M | -45.41M | -31.36M | -19.04M | -9.32M |
Interest Income | 43.53M | 43.52M | 44.97M | 28.73M | 29.2M | 28.83M | 26.63M | 23.2M | 17.59M | 11.42M | 6.92M | 5.01M | 2.73M | 1.96M | 910K |
Pretax Income | -224.38M | -186.75M | -161M | -151.48M | -128.08M | -105.56M | -88.04M | -72.36M | -63.72M | -56.43M | -48.16M | -40.44M | -28.67M | -17.06M | -8.39M |
Net Income | -224.38M | -186.75M | -161M | -151.48M | -128.08M | -105.56M | -88.04M | -72.36M | -63.72M | -56.43M | -48.16M | -40.44M | -28.67M | -17.06M | -8.39M |
Selling & General & Admin | 91.08M | 79.52M | 73.53M | 67.24M | 52.62M | 42.7M | 33.7M | 25.01M | 18.61M | 13.61M | 9.89M | 8.53M | 6.22M | 3.73M | 1.65M |
Research & Development | 156.23M | 132.9M | 116.64M | 113.48M | 105.22M | 92.36M | 82.1M | 71.22M | 63.33M | 54.69M | 45.32M | 37.07M | 25.33M | 15.5M | 7.66M |
Other Expenses | 155K | -31.18M | -58.64M | -85.6M | -105.22M | -92.36M | -64.89M | -38.09M | -30.21M | -11.79M | -19.64M | -19.62M | -7.89M | -7.83M | 13K |
Operating Expenses | 247.47M | 181.25M | 131.53M | 95.12M | 52.62M | 42.7M | 50.91M | 58.13M | 51.73M | 56.56M | 35.64M | 26.02M | 23.71M | 11.38M | 9.31M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -4K | -8K | -8K | -12K | -8K | -8K | -8K | -4K | -4K |
Cost & Expenses | 258.85M | 220.03M | 194.81M | 182.3M | 157.84M | 135.06M | 115.81M | 96.23M | 81.95M | 68.31M | 55.23M | 45.61M | 31.56M | 19.23M | 9.32M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 88.2M | 84.52M | 77.3M | 76.73M | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
Shares Outstanding (Diluted) | 88.2M | 84.52M | 77.3M | 76.73M | 76.23M | 76.19M | 64.82M | 67.14M | 66.65M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M | 66.64M |
EPS (Basic) | -2.70 | -2.34 | -2.08 | -2.05 | -1.78 | -1.52 | -1.32 | -1.16 | -1.14 | -1.03 | -0.91 | -0.71 | -0.43 | -0.26 | -0.13 |
EPS (Diluted) | -2.70 | -2.34 | -2.08 | -2.05 | -1.78 | -1.52 | -1.29 | -1.13 | -1.11 | -1 | -0.91 | -0.71 | -0.43 | -0.26 | -0.13 |
EBITDA | -222.27M | -184.48M | -159.55M | -150.89M | -127.88M | -105.51M | -88.01M | -72.32M | -63.7M | -56.41M | -48.15M | -41.54M | -29.78M | -18.17M | -9.51M |
EBIT | -224.38M | -186.75M | -161M | -151.48M | -128.08M | -105.56M | -88.04M | -72.36M | -63.72M | -56.43M | -48.16M | -41.56M | -29.79M | -18.18M | -9.51M |
Depreciation & Amortization | 2.11M | 2.26M | 1.45M | 596K | 201K | 52K | 32K | 36K | 19.33K | 16.33K | 16.33K | 16.33K | 12K | 8K | 4K |
Add to Watchlist
Select watchlists to add or remove CGON